A new kind of cancer drug has proven promising effects in Period 1 trials right after blocking tumor advancement in far more than fifty percent of patients who did not have access to any other procedure. Called berzosertib, the drug is portion of “precision medicine” therapies that goal unique genes or genetic variations. Berzosertib operates best when blended with traditional chemotherapy. The latter destroys cancerous cells but has facet effects on the whole system, and…

Pin It